International Drug Prices

Evidence from STRIDE

Published in: CNC Roundtable Drug Conference, Jan. 29, 2003, p. 1-25

Posted on on December 31, 2002

by Jonathan P. Caulkins

Most of the principal illicit drugs used in the US are produced overseas, so international markets for these substances bear on US drug availability, prices, use, and consequences. Prices are a key characteristic of these markets, but international drug prices information in the open literature primarily consists of summary or representative figures cited in official publications. This paper seeks to augment that information base by systematically examining international prices observations in the Drug Enforcement Administration's STRIDE database. Results are generally consistent with conventional reporting of these prices. Some evidence of quantity discounts (alternately, price markups along the distribution chain) is found in source and transshipment countries.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.